Neostigmine Methylsulfate 51662-1557
Product NDC
51662-1557- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 14, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA209933
Need to source Neostigmine Methylsulfate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Neostigmine Methylsulfate | 1 mg/mL |
Drug Class
Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitors [MoA]
Packaging Options(1)
10 POUCH in 1 CASE (51662-1557-3) / 1 CARTON in 1 POUCH (51662-1557-2) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE